NCT00471887 Ticilimumab (CP-675,206) in Treating Patients With Stage IIIC or Stage IV Melanoma Status COMPLETED Phase PHASE2
NCT00471276 Efficacy And Safety Of Sunitinib In Women With Advanced Breast Cancer Status COMPLETED Phase PHASE2
NCT00471224 A Prospective Safety Follow Up Study Of Subjects Enrolled In Study A4321001 And Who Have Received Drug Product Status COMPLETED Phase N/A
NCT00471172 Study of Five Different Methods Of Delivering A Lifestyle Modification Program for Weight Loss Status COMPLETED Phase NA
NCT00471159 A Study Of Docetaxel Or Docetaxel Plus PF-3512676 To Treat Patients With Advanced Breast Cancer. Status WITHDRAWN Phase PHASE2
NCT00471146 Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer. Status COMPLETED Phase PHASE3
NCT00469105 Improving Care for Primary Care Patients With Diabetes and Poor Literacy and Numeracy Skills Status COMPLETED Phase PHASE4
NCT00468975 A Blinded Study To Examine The Ability Of PF-610,355 To Open The Airways In Asthmatic Patients. Status COMPLETED Phase PHASE2
NCT00468637 Association of Multiple CardiOvascular Risk Factors and Erectile Function Across Europe Status UNKNOWN Phase N/A
NCT00467766 Combining a Caregiver Intervention With Aricept Treatment for Mild to Moderate Alzheimer's Disease Status COMPLETED Phase NA
NCT00465894 Detrol Long Acting (LA) vs Estrace Vaginal Cream for the Treatment of Overactive Bladder Symptoms Status COMPLETED Phase NA
NCT00465179 Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer Status COMPLETED Phase PHASE2
NCT00463918 A Phase I Study to Evaluate the Pharmacokinetics of Multiple Doses of Varenicline in Healthy Adolescent Smokers Status COMPLETED Phase PHASE1
NCT00463762 Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And Hepatobiliary Infections. Status WITHDRAWN Phase N/A
NCT00463372 Study Investigating the Safety and Tolerability of Multiple Doses of PF-02545920 in Subjects With Schizophrenia Status COMPLETED Phase PHASE1
NCT00463060 Sutent and Radiation as Treatment for Limited Extent Metastatic Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00460603 Study With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2